Shanghai Shen Lian Biomedical Corporation (SHA:688098)

SHA:688098 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	64.88	122	146.21	44.98	52.74	44.21
Trading Asset Securities	0.71	32.82	43.81	162.38	305.12	424.08
Cash & Short-Term Investments	65.59	154.82	190.02	207.35	357.87	468.29
Cash Growth	-49.14%	-18.52%	-8.36%	-42.06%	-23.58%	-20.23%
Accounts Receivable	316.14	282.11	261.4	273.97	222.76	154.61
Other Receivables	2.8	3.33	3.17	3.09	6.82	5.99
Receivables	318.94	285.44	264.57	277.06	229.57	160.61
Inventory	117.83	94.47	95.1	111.79	115.33	103.42
Other Current Assets	5.58	1.17	1.14	2.09	2.74	1.14
Total Current Assets	507.93	535.9	550.83	598.29	705.5	733.46
Property, Plant & Equipment	776.77	799.83	811.19	823.31	776.66	768.55
Long-Term Investments	92.09	26.46	6.58	1.59	1.58	1.57
Other Intangible Assets	122.53	124.7	102.66	93.6	53.12	32.66
Long-Term Deferred Tax Assets	18.01	14.47	13.26	5.14	6.5	7.08
Long-Term Deferred Charges	16.33	15.4	33.18	42.35	42.17	35.52
Other Long-Term Assets	13.88	25.62	36.41	29.72	19.56	19.62
Total Assets	1,548	1,542	1,554	1,594	1,605	1,598

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	13.05	16.43	5.44	5.14	8.86	11.33
Accrued Expenses	5.68	57.56	57.82	42.8	48.37	58.72
Short-Term Debt	52.36	12.89	14.01	-	-	-
Current Portion of Long-Term Debt	0.33	-	-	-	-	-
Current Portion of Leases	-	0.37	0.48	0.33	0.14	0.13
Current Income Taxes Payable	0.52	0	-	0.23	7.58	5.09
Current Unearned Revenue	9.27	25.01	19.59	6.65	10.61	8.92
Other Current Liabilities	62.23	21.07	18.86	21.35	21.66	29.33
Total Current Liabilities	143.45	133.33	116.2	76.5	97.22	113.53
Long-Term Leases	0.76	0.92	1.01	0.92	0.31	0.38
Long-Term Unearned Revenue	8.12	9.11	11.08	9.49	10.36	11.3
Long-Term Deferred Tax Liabilities	0.03	0.06	0.21	0.02	0.32	0.27
Total Liabilities	152.36	143.41	128.5	86.93	108.21	125.48

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	410.64	410.64	410.64	410.64	410.64	410.64
Additional Paid-In Capital	535.8	539.23	539.23	539.23	546.04	552.18
Retained Earnings	440.1	459.25	479.74	538.85	540.19	516.05
Treasury Stock	-	-20	-18.32	-	-	-
Total Common Equity	1,387	1,389	1,411	1,489	1,497	1,479
Minority Interest	8.64	9.85	14.33	18.34	-	-5.89
Shareholders' Equity	1,395	1,399	1,426	1,507	1,497	1,473
Total Liabilities & Equity	1,548	1,542	1,554	1,594	1,605	1,598

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	53.45	14.17	15.49	1.25	0.45	0.51
Net Cash (Debt)	12.14	140.65	174.53	206.1	357.42	467.78
Net Cash Growth	-89.33%	-19.41%	-15.32%	-42.34%	-23.59%	-20.32%
Net Cash Per Share	0.03	0.34	0.43	0.52	0.88	1.15
Filing Date Shares Outstanding	-	407.23	407.53	410.64	410.64	379.56
Total Common Shares Outstanding	-	407.23	407.53	410.64	410.64	379.56
Working Capital	364.49	402.57	434.63	521.79	608.29	619.93
Book Value Per Share	-	3.41	3.46	3.63	3.65	3.90
Tangible Book Value	1,264	1,264	1,309	1,395	1,444	1,446
Tangible Book Value Per Share	-	3.10	3.21	3.40	3.52	3.81
Buildings	-	363.63	343.74	318.94	298.9	285.68
Machinery	-	714.47	600.61	595.91	577.97	495.93
Construction In Progress	-	95.06	177.87	163.44	98.95	133.78

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error